Pharmacy Podcast Network - TopPodcast.com

View Top 200 Chart

Back to Rankings Page

Pharmacy Podcast Network — Business
Pharmacy Podcast Network

Pharmacy Podcast Network (PPN) is the world’s largest network of podcasts dedicated to the pharmacy professional and industry insiders. Our content is about dynamic people in the pharmacy industry making a difference and delivering the best pharmacy care. We have over 40+ podcasts with thousands of interviews.

Pharmacists are the cornerstone of healthcare, and the PPN reflects that. From Community, LTC, Specialty Pharmacy to Drug Development, Government policy and DigitalHealth, we cover it all. Partner with us to connect with thousands of daily listeners and find the right pharmacist across various specialties and topics, ensuring your products and services resonate where it matters most. We build strong audio brands through Pharmacists who see patients almost 9x more than primary care.

Join the home of the O.G. Pharmacy Podcast & discover our newest development: Evidence-based Podcasting, the first CME supplement in podcast form that’s truly peer-reviewed. The future of podcasting education for Providers is “Evidence-based Podcasting” (TM) and we’re building a peer-review board, reach out to us: Publisher @ Pharmacy Podcast dot com.

PPN is a division of RxPR, LLC. Copyright 2026

Latest Episodes:

Proactive Management of Adverse Effects Associated With Waldenström Macroglobulinemia | PTCE Pharmacy Connect Dec 23, 2021

Show notes

Educational Objective Identify best practices for managing toxicities associated with therapies for the treatment of Waldenström macroglobulinemia Faculty: Victoria Nachar, PharmD, BCOP Clinical Pharmacist Specialist, Ambulatory Hematology Oncology University of Michigan Rogel Cancer Center Clinical Assistant Professor University of Michigan College of Pharmacy Ann Arbor, Michigan Faculty has no financial relationships with commercial interests to disclose. Pharmacy Times Continuing Education™ is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This activity is approved for 0.5 contact hour (0.05 CEU) under the ACPE universal activity number 0290-0000-21-457-H01-P. The activity is available for CE credit through June 20, 2022. This activity is supported by educational grants from Pharmacyclics LLC., an AbbVie Company and Janssen Biotech, Inc; and BeiGene, Ltd. Learn more about your ad choices. Visit megaphone.fm/adchoices

Health Benefits Innovation: Delivering Better Patient Care includes Preemptive Strategies Dec 23, 2021

Show notes

About ALVA-10 For far too long there has been a gap between payers and diagnostic companies where diagnostic technology has been characterized as “expensive and unnecessary”, because it has been poorly understood, undervalued and underutilized. Alva10 was established in response to this divide. With years of experience in pharmaceutical and diagnostic companies, Founders Hannah Mamuszka and Lena Chaihorsky built a team and company dedicated to narrowing that knowledge gap. Armed with and driven by knowledge, curiosity and a passion to innovate the industry, Alva10 set out to redesign the healthcare system while restructuring current spiraling healthcare spend. Read more about how Alva10 was founded here. Alva10 reduces ineffective therapeutic spend through customized solutions that provide advanced knowledge of patients’ ability to respond to costly therapies before they are given. Through our proprietary model M.A.T.E. we restructure the relationship between health insurance payers and Precision Medicine diagnostic companies. The result of this new way of doing business is a broad range of completely novel healthcare tools that directly solve the large clinical and economic challenges for payers and providers. Lena Chaihorsky | Co-Founder ALVA-10 Lena is the co-founder and Vice President of Payer Innovation at Alva10. With a background in biology and mathematics from Tufts, she is a skilled healthcare executive with a proven track record of developing and executing value based reimbursement strategies for diagnostics companies. Lena has extensive leadership experience in sales, national contracting, and all aspects of reimbursement within start-up and global companies, most recently AmniSure and QIAGEN. Lena also contributes to Alva10’s public speaking and writing efforts, leveraging her unique perspective on payer business and innovation models and their intersections with the diagnostics industry. Her work on commercial approaches to health economics data analysis led to her appointment as co-chair of the World Economic Forum’s workgroup dedicated to the economics of rare disease data federations in 2019. She is active within the Tufts Alumni Career Networking Community, and both a mentor and mentee within the HLTH Foundation’s CSweetener , a 501(c) 3 charity working toward healthcare equality, diversity and access by empowering women to seek and obtain mentorship from industry leaders. About PBGH - Pittsburgh Business Group on Health Since the 1980s, the Pittsburgh Business Group on Health has been driving change in healthcare – giving a voice to employers in their efforts to contain rising costs for care and prescription drugs that are suppressing the ability of their employees to receive the care they need when they need at a price they can afford. More than 100 leading employers from across southwestern Pennsylvania enjoy the benefits of and solutions provided by PBGH – one of the nation’s leading non-profit organizations dedicated to helping companies protect and promote their ability to provide high-quality, equitable and affordable healthcare for their employees. From award-winning prescription drug containment initiatives to nationally renowned educational programs for human resources, benefits managers and C-suite officers, PBGH delivers the comprehensive cost-savings and health and wellness solutions companies need today to drive and implement change in healthcare. PBGH’s targeted voice advocates for employers at the highest local, state and federal levels – lobbying and pursuing real transformation in the way healthcare is delivered and paid for so companies and organizations have the power to be competitive and succeed so our region thrives. Jessica Brooks | President & CEO PBGH Learn more about your ad choices. Visit megaphone.fm/adchoices

The Vision for the Role of the Pharmacist in 2022 with Dr. Thomas Franko, PharmD Dec 22, 2021

Show notes

In this episode, Dr. Thomas Franko, PharmD, president of the Pennsylvania Pharmacist's Association talks with Todd Eury, CEO & Founder of the Pharmacy Podcast Network about his 'Vision for the Role of the Pharmacist in 2022'. Most people see pharmacists behind the counter dispensing pills and occasionally giving advice on prescription and over the counter (OTC) medications; they may sometimes remind customers of preventive screenings or flu shots. But pharmacists are capable of much more. As part of their professional degree, they receive extensive training on medication management to optimize treatment options, manage medication side effects, interactions and duplications, interpret lab results, perform physical exams, and administer vaccines. --from Deloitte Insights The pandemic increased opportunities for pharmacists to deliver hands-on care. The Department of Health and Human Services (HHS) gave pharmacists the authority to order and administer COVID-19 tests, childhood vaccines (3–18 years of age), and COVID-19 vaccines.4 Subsequently, pharmacists, interns, and pharmacy technicians were on the front lines, testing for COVID-19, giving shots, and educating the public, all the while keeping their doors open throughout the pandemic. These efforts elevated the public's perception of pharmacists and offset the burden on other parts of the health care system, providing an opportunity for the profession to redefine its role and value. About Dr. Thomas Franko, PharmD Dr. Franko is the PPA's on-coming President for 2022. After service as a clinical pharmacist in outpatient chronic pain management, Dr. Franko joined Wilkes University in 2013. He maintains an ambulatory care practice site with the Wright Center for Graduate Medical Education in Kingston, PA. He is involved with medication therapy management for several chronic diseases, especially pain management, at the Wright Center. Along with pharmacy students, Dr. Franko trains pharmacy and medical residents from Moses Taylor Hospital and The Wright Center. He is an active member of the American Pharmacists Association, American Association of Colleges of Pharmacy and the Pennsylvania Pharmacists Association. His interests are in pain management, substance use disorder and harm reduction strategies. Education and Training Doctor of Pharmacy, Philadelphia College of Pharmacy, Philadelphia, PA Pharmacy Practice Residency, Veterans Affairs Medical Center, Wilkes-Barre, PA Learn more about your ad choices. Visit megaphone.fm/adchoices

Empowering People to Live Healthier Lives, a special podcast with Dr. Richard Ashworth | The Public Health Pharmacist Dec 21, 2021

Show notes

Empowering People to Live Healthier Lives, a special podcast with Dr. Richard Ashworth Pharmacists, Physcians, and people commited to better health for our nation are working closer than ever before. Dr. Richard Ashworth believes we can do more. Interesting insights on how the healthy aging sector will evolve post-pandemic – including concerns on reported increased levels of stress in seniors and the need to more actively address social determinants of health. Dr. Ashworth and Dr. Madison also talk about navigating the shift to virtual engagement and the opportunities and challenges healthcare organizations will face once the nation fully reopens from COVID-19. Our guest: Dr. Richard Ashworth, PharmD joined Tivity Health as President and CEO, and as a member of the Board of Directors, in June 2020. Previously, Ashworth facilitated the growth of Walgreens for nearly 30 years, transforming the company into a global leader in pharmacy and health and wellness. He started at Walgreens as a store clerk in 1992, and most recently led as President, responsible for developing the strategies and plans for all Walgreens operations including leadership, development and management of the business. Ashworth has spent his career focused on improving the health and well-being of others, with a passion for making a difference in the lives of customers and members. His experience includes navigating a rapidly changing healthcare landscape while serving a portfolio of large customers and individual consumers in the intensely competitive retail realm. Ashworth is an influential voice in public health policy and the future of healthcare and has shared his views at the White House and on Capitol Hill. He also served on the NACDS board for the last four years, formerly as Chairman. Ashworth earned a Doctor of Pharmacy degree (PharmD) and a master's degree in business administration. Our host: Dr. Christina Madison, PharmD is the Founder and CEO of The Public Health Pharmacist™, PLLC a public health consulting firm. She is a clinical pharmacist specializing in public health with a focus on infectious communicable diseases. As a past President of the Nevada Public Health Association, she has been asked to share her clinical public health and infectious disease expertise with Local, State, and International Media outlets and NGO’s. Dr. Madison has been featured in over 200+ on-air TV appearances since January 2020 related to the pandemic and public health. She has an intimate knowledge of the impact public health messaging, policy, and legislation can have on communities. Learn more about your ad choices. Visit megaphone.fm/adchoices

Enhance Care Decision Making with Evidence & AI | Pharmacy Talk with IBM Watson Heatlh Dec 21, 2021

Show notes

Special guests: Alan Ehrlich, Executive Editor at DynaMed and an Associate Professor in Family Medicine at the University of Massachusetts Medical School in Worcester Bio: Alan Ehrlich, MD, FAAFP is the Executive Editor at DynaMed and an Associate Professor in Family Medicine at the University of Massachusetts Medical School in Worcester. He is board certified from the American Board of Family Medicine and a Fellow of the American Academy of Family Physicians. Alan graduated from Rutgers New Jersey Medical School in 1984 and completed his residency at the University of Massachusetts Medical Center in 1987. He is involved in the teaching of Evidence-Based Medicine to third year medical students and writes the Evidence-Based Medicine column for Clinical Advisor magazine. Eileen Yoshida, Deputy Editor of Medication and Clinical Informatics, EBSCO Health Bio: Eileen Yoshida is the Deputy Editor of Medication and Clinical Informatics at EBSCO Health. In this role, she leads the medication and clinical informatics strategies for the organization. Eileen brings over 25 years of experience in the healthcare industry, most recently leading the Clinical Knowledge Management and Decision Support team at Partners HealthCare. Previously, she served with Capgemini as an EHR implementation strategist and with the University of Chicago Hospitals in a special project’s role. Eileen has extensive experience in clinical informatics, EHR implementation, healthcare consulting and clinical pharmacy and is a published author and speaker on clinical decision support. She holds a degree in Pharmacy from the University of Toronto and a master’s in business administration from the Kellogg School of Management at Northwestern University. Research: Report from HIMSS19: Novel Techniques to Combat the Opioid Misuse Epidemic Courtney Holmes, RN, Executive Clinical Consultant, IBM Watson Health Bio: Courtney Holmes is a Clinical Program Director supporting IBM’s Micromedex solution suite, as well as an Executive Clinical Consultant with Watson Health. Courtney focuses on providing clinical leadership in the sales and development of cognitive solutions and engagement with key stakeholders to support meaningful use of Watson Health solutions. She provides subject matter expertise for the Healthcare. Provider Segment. This includes providing strategic and clinical expertise to ensure high value development/improvements and intuitive, seamless clinical workflow design. Courtney collaborates among global product offerings teams to ensure clinically relevant approaches to client engagements, and leads Watson Health solution sales activities through client briefings, demonstration of solutions, workshops and other formats as needed. Ms. Holmes joined IBM in 2018 and brings 17 years of extensive oncology nursing experience to the team. Her experience ranges from direct clinical care at some of the top hospitals in the country, to developing the nurse educator program for a large pharmaceutical company and leading a team of nurses in her region. Courtney spent time building strong customer relationships with key nursing organizations, targeted accounts, and other identified key customers. She also focused on providing clinical expertise and support to sales to optimize overall customer experience, as well as helping facilities achieve better patient outcomes by improving overall quality of care and providing insight on best practices. Blog post: https://www.ibm.com/blogs/watson-health/how-ai-infused-clinical-decision-support-may-change-medicine/ Learn more about your ad choices. Visit megaphone.fm/adchoices

Risk-based Care Can Drive Better Patient Adherence Dec 20, 2021

Show notes

Participants and Roles: Sheila Arquette, President & CEO, NASP, Host/Interviewer Purpose: Discuss how implementing risk-based care benefits patients and can improve their adherence rates Ashleigh Burdette, MSN, RN, is the Sr. Director of Clinical Innovation with Biologics by McKesson. Ashleigh has been a Registered Nurse for nearly 15 years and holds a Master of Science in Nursing with a specialization in leadership and administration. She began her nursing career as an oncology nurse working in both bone marrow transplant and an outpatient clinic. In 2015, she joined Optum/United Health Group to focus on oncology patient support, utilization review, and clinical case management. In 2017, she joined Cardinal Health’s hub business and had the opportunity to lead both clinical operations and account management. Ashleigh joined Biologics by McKesson in 2020 to lead cross-functional collaboration to create customized patient management solutions that support the holistic needs of patients. · What is risked-based care, and how does it differ from “standardized care”? · What’s the methodology behind risked-based care? · Is the nurse-patient connection important? Why or why not? · What are some outcomes you’ve seen with this type of personalized level of care and support? · If someone wanted to implement this type of tailored support in their care setting, what are some of the essential components to keep in mind? Contact the NASP: https://naspnet.org/about Learn more about your ad choices. Visit megaphone.fm/adchoices

phactMI: Where Pharmacists Go for Medical Information Dec 20, 2021

Show notes

Where Pharmacists Go for Medical Information Due to the advancement of technology, healthcare professionals have access to a wealth of medical information in just a few strokes of their keyboard. Thinking of the quantity of resources available brings up the question, what sources of information are actually being used to inform treatment decisions? Join us in this episode where Patrick Reilly, PA, CEO phactMI and guest speakers John Jones, MBA, Director of Technology phactMI and Evelyn Hermes-DeSantis, PharmD, BCPS, Director, Research and Publications, phactMI/ Professor Emerita, Rutgers, The State University of New Jersey discuss the most common sources of medical information and the role of manufacturers in providing scientifically accurate information. This is the second episode in a series of three podcasts. If you have not listened to our first episode, check it out with the link below: ● phactMI: Collaborate, Elevate, Enhance Patient Care: https://pharmacypodcast.com/2021/12/11/phactmi-podcast-series/ Learn more about phactMI at www.phactMI.org/about/ Follow phactMI on LinkedIn, Facebook, and Twitter Learn more about your ad choices. Visit megaphone.fm/adchoices

Strategies for Pharmacist Involvement in Adverse Effect Management | PTCE Pharmacy Connect Dec 19, 2021

Show notes

Educational Objectives · Recognize best practices for managing adverse effects associated with immune checkpoint inhibitor (ICI)-targeted therapy combinations Faculty: Jacob K. Kettle, PharmD, BCOP Pharmacy Manager Ellis Fischel Cancer Center Department of Pharmacy University of Missouri Health Care Columbia, Missouri Faculty, has the following financial relationships with commercial interests to disclose: Jacob Kettle, PharmD, BCOP, has the following relevant financial relationships with commercial interests to disclose: Speakers Bureau: Genentech, Merck, Amgen, Lilly, DSI Consultant: Pfizer, Lilly Pharmacy Times Continuing Education™ is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This activity is approved for 0.75 contact hours (0.075 CEU) under the ACPE universal activity number 0290-0000-21-438-H01-P. The activity is available for CE credit through December 17, 2022. This activity is supported by educational grants from Eisai Inc and Exelixis, Inc. Learn more about your ad choices. Visit megaphone.fm/adchoices

Establishing the Role of Targeted Therapies in Cancer Care | PTCE Pharmacy Connect Dec 18, 2021

Show notes

Educational Objectives · Describe the role of immune checkpoint inhibitor (ICI)-targeted therapy combinations across malignancies · Recall knowledge of ICI-targeted therapy combinations to treatment selection in patients with cancer Faculty: Jacob K. Kettle, PharmD, BCOP Pharmacy Manager Ellis Fischel Cancer Center Department of Pharmacy University of Missouri Health Care Columbia, Missouri Faculty, has the following financial relationships with commercial interests to disclose: Jacob Kettle, PharmD, BCOP, has the following relevant financial relationships with commercial interests to disclose: Speakers Bureau: Genentech, Merck, Amgen, Lilly, DSI Consultant: Pfizer, Lilly Pharmacy Times Continuing Education™ is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This activity is approved for 0.5 contact hours (0.05 CEU) under the ACPE universal activity number 0290-0000-21-437-H01-P. The activity is available for CE credit through December 17, 2022. This activity is supported by educational grants from Eisai Inc and Exelixis, Inc. Learn more about your ad choices. Visit megaphone.fm/adchoices

First Steps to Compounding Technology | The Future of Pharmacy Dec 16, 2021

Show notes

Introduction As the safety of compounding practices comes under renewed scrutiny from authoritative bodies, more attention is being paid to assistive and robotic technologies. Learn how a stepped approach to adopting compounding technology can lead to safer, more efficient, and cost effective compounding operations. Participants Host: Ken Perez, Vice President, Healthcare Policy and Government Affairs, Omnicell, Inc. Guest Expert: Kevin N. Hansen, PharmD, MS, BCPS, BCSCP, Assistant Director of Pharmacy, Moses H. Cone Memorial Hospital Learn more about your ad choices. Visit megaphone.fm/adchoices

Related Podcasts